The BOPA Digital SACT Verification Passport is now LIVE!

On Sunday 8th October 2023, Netty Cracknell, Lead Cancer Pharmacist at Ramsay Health Care UK / BOPA Verification Project Lead and Jonathan Knight, CEO and co-founder of Tefogo, launched the BOPA Digital SACT Verification Passport at the 26th BOPA Annual Symposium in Wales.

The concept of the passport allows staff to move between organisations throughout the UK without the need for complete re-training and validation due to the accreditation record being held by an individual rather than the hiring organisation. In a digital format it also has the added benefits of portability, ease of access, auditability and fully assured digital sign-off.
It is available free for BOPA free associates or BOPA paid members to access via the BOPA website.

Thank you everyone who volunteered and helped make this happen.

Netty Cracknell
BOPA Verification Project lead

Heather Dalrymple– Standards pillar lead
Clayton Wong – eLearning pillar lead
Michal Sladkowski– Assessment pillar lead
Sana Mahmood– Digital passport pillar lead with Netty
Raakhee Shah – HSCT pillar lead
Vicky Holden and Lamia Samrin – Paediatric pillar leads

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article